ReviewDrugs in R&D2024

Antibody-Drug Conjugates in the Pipeline for Treatment of Melanoma: Target and Pharmacokinetic Considerations.

Ina Lami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.